AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

IOXAGLATE DE SODIUM ET DE MEGLUMINE

10 registrations across 1 African market— 10 active

Markets with IOXAGLATE DE SODIUM ET DE MEGLUMINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive
HEXABRIX
SOLUTION INJECTABLE
🇲🇦Moroccoactive

IOXAGLATE DE SODIUM ET DE MEGLUMINE in Africa — Regulatory Overview

IOXAGLATE DE SODIUM ET DE MEGLUMINE is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.